<DOC>
	<DOCNO>NCT00830063</DOCNO>
	<brief_summary>The purpose study test efficacy safety 2 dos tanezumab compare naproxen placebo patient osteoarthritis .</brief_summary>
	<brief_title>Tanezumab In Osteoarthritis Of The Knee ( 2 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Osteoarthritis knee accord KellgrenLawrence xray grade 2 Pregnancy intent become pregnant BMI great 39 severe pain , significant cardiac , neurologic cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>monoclonal antibody</keyword>
	<keyword>RN624</keyword>
	<keyword>PF-04383119</keyword>
	<keyword>nerve growth factor</keyword>
	<keyword>anti-nerve growth factor</keyword>
	<keyword>OA</keyword>
	<keyword>pain</keyword>
</DOC>